Immune thrombocytopenia as a paraneoplastic syndrome in patients with nasopharyngeal cancer

Background Nasopharyngeal cancer (NPC) presenting with thrombocytopenia is rare. This report details 2 cases of NPC with grade III thrombocytopenia as a paraneoplastic syndrome. Methods We present 2 cases of NPC in whom grade III thrombocytopenia was diagnosed concurrently at presentation. One patie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Head & neck 2012-01, Vol.34 (1), p.127-130
Hauptverfasser: Yang, Kunyu, Zhang, Tao, Chen, Jing, Fan, Li, Yin, Zhongyuan, Hu, Yu, Wu, Gang, Rosenthal, Eben L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 130
container_issue 1
container_start_page 127
container_title Head & neck
container_volume 34
creator Yang, Kunyu
Zhang, Tao
Chen, Jing
Fan, Li
Yin, Zhongyuan
Hu, Yu
Wu, Gang
Rosenthal, Eben L.
description Background Nasopharyngeal cancer (NPC) presenting with thrombocytopenia is rare. This report details 2 cases of NPC with grade III thrombocytopenia as a paraneoplastic syndrome. Methods We present 2 cases of NPC in whom grade III thrombocytopenia was diagnosed concurrently at presentation. One patient underwent definitive intensity‐modulated radiation therapy (IMRT) in combination with concurrent cetuximab, the other with cisplatin. Both patients received adjuvant chemotherapy composed of docetaxel and cisplatin. Results The cause of their grade III thrombocytopenia was diagnosed as immunologic in origin. Prednisone was administered before IMRT, and their peripheral platelet counts recovered to normal levels. Their platelet counts fell below normal levels several times during their treatment. However, their radiotherapy and chemotherapy had never been interrupted due to thrombocytopenia. Conclusion Grade III thrombocytopenia is a rare paraneoplastic syndrome in patients with NPC. These patients can tolerate the aggressive definitive management of radiotherapy and chemotherapy with supportive care. © 2010 Wiley Periodicals, Inc. Head Neck, 2012
doi_str_mv 10.1002/hed.21481
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_911936022</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>911936022</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3541-a0a9a6f3e2ebab06515252011d7ae3e21bd2c38b077c16ff1e3aade8cf939a133</originalsourceid><addsrcrecordid>eNp10DtPwzAQB3ALgaAUBr4A8oIQQ9qznUczovJopUosMDFEF-dCjRInxIlQvz3uAzEx2br76e70Z-xKwEQAyOmaiokU4UwcsZGANAlAhcnx9h-qQEESnrFz5z4BQMWhPGVnEuI4SkI5Yu_Luh4s8X7dNXXe6E3ftGQNcnQceYsdWmraCl1vNHcbW3hG3Fjf6g3Z3vFv06-5Rde0a-w29oOw4hqtpu6CnZRYObo8vGP29vT4Ol8Eq5fn5fx-FWgVhSJAwBTjUpGkHHOIIxHJSIIQRYLkqyIvpFazHJJEi7gsBSnEgma6TFWKQqkxu93PbbvmayDXZ7Vxmqpqe_vgslSIVMUgpZd3e6m7xrmOyqztTO3PzgRk2ygzH2W2i9Lb68PUIa999Vf-ZufBzQGg01iVPipt3J-LIpDhzk337ttUtPl_Y7Z4fNiv_gH0DIvS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>911936022</pqid></control><display><type>article</type><title>Immune thrombocytopenia as a paraneoplastic syndrome in patients with nasopharyngeal cancer</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Yang, Kunyu ; Zhang, Tao ; Chen, Jing ; Fan, Li ; Yin, Zhongyuan ; Hu, Yu ; Wu, Gang ; Rosenthal, Eben L.</creator><creatorcontrib>Yang, Kunyu ; Zhang, Tao ; Chen, Jing ; Fan, Li ; Yin, Zhongyuan ; Hu, Yu ; Wu, Gang ; Rosenthal, Eben L.</creatorcontrib><description>Background Nasopharyngeal cancer (NPC) presenting with thrombocytopenia is rare. This report details 2 cases of NPC with grade III thrombocytopenia as a paraneoplastic syndrome. Methods We present 2 cases of NPC in whom grade III thrombocytopenia was diagnosed concurrently at presentation. One patient underwent definitive intensity‐modulated radiation therapy (IMRT) in combination with concurrent cetuximab, the other with cisplatin. Both patients received adjuvant chemotherapy composed of docetaxel and cisplatin. Results The cause of their grade III thrombocytopenia was diagnosed as immunologic in origin. Prednisone was administered before IMRT, and their peripheral platelet counts recovered to normal levels. Their platelet counts fell below normal levels several times during their treatment. However, their radiotherapy and chemotherapy had never been interrupted due to thrombocytopenia. Conclusion Grade III thrombocytopenia is a rare paraneoplastic syndrome in patients with NPC. These patients can tolerate the aggressive definitive management of radiotherapy and chemotherapy with supportive care. © 2010 Wiley Periodicals, Inc. Head Neck, 2012</description><identifier>ISSN: 1043-3074</identifier><identifier>EISSN: 1097-0347</identifier><identifier>DOI: 10.1002/hed.21481</identifier><identifier>PMID: 20665742</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Biological and medical sciences ; Chemotherapy, Adjuvant ; Epstein–Barr virus ; Female ; Hematologic and hematopoietic diseases ; Humans ; immune thrombocytopenia ; IMRT ; Male ; Medical sciences ; nasopharyngeal cancer ; Nasopharyngeal Neoplasms - complications ; Nasopharyngeal Neoplasms - drug therapy ; Nasopharyngeal Neoplasms - radiotherapy ; Otorhinolaryngology. Stomatology ; paraneoplastic syndrome ; Paraneoplastic Syndromes - diagnosis ; Paraneoplastic Syndromes - drug therapy ; Platelet diseases and coagulopathies ; Purpura, Thrombocytopenic, Idiopathic - diagnosis ; Purpura, Thrombocytopenic, Idiopathic - drug therapy ; Radiotherapy, Intensity-Modulated ; Tumors ; Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</subject><ispartof>Head &amp; neck, 2012-01, Vol.34 (1), p.127-130</ispartof><rights>Copyright © 2010 Wiley Periodicals, Inc.</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3541-a0a9a6f3e2ebab06515252011d7ae3e21bd2c38b077c16ff1e3aade8cf939a133</citedby><cites>FETCH-LOGICAL-c3541-a0a9a6f3e2ebab06515252011d7ae3e21bd2c38b077c16ff1e3aade8cf939a133</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhed.21481$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhed.21481$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,4009,27902,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25502442$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20665742$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Kunyu</creatorcontrib><creatorcontrib>Zhang, Tao</creatorcontrib><creatorcontrib>Chen, Jing</creatorcontrib><creatorcontrib>Fan, Li</creatorcontrib><creatorcontrib>Yin, Zhongyuan</creatorcontrib><creatorcontrib>Hu, Yu</creatorcontrib><creatorcontrib>Wu, Gang</creatorcontrib><creatorcontrib>Rosenthal, Eben L.</creatorcontrib><title>Immune thrombocytopenia as a paraneoplastic syndrome in patients with nasopharyngeal cancer</title><title>Head &amp; neck</title><addtitle>Head Neck</addtitle><description>Background Nasopharyngeal cancer (NPC) presenting with thrombocytopenia is rare. This report details 2 cases of NPC with grade III thrombocytopenia as a paraneoplastic syndrome. Methods We present 2 cases of NPC in whom grade III thrombocytopenia was diagnosed concurrently at presentation. One patient underwent definitive intensity‐modulated radiation therapy (IMRT) in combination with concurrent cetuximab, the other with cisplatin. Both patients received adjuvant chemotherapy composed of docetaxel and cisplatin. Results The cause of their grade III thrombocytopenia was diagnosed as immunologic in origin. Prednisone was administered before IMRT, and their peripheral platelet counts recovered to normal levels. Their platelet counts fell below normal levels several times during their treatment. However, their radiotherapy and chemotherapy had never been interrupted due to thrombocytopenia. Conclusion Grade III thrombocytopenia is a rare paraneoplastic syndrome in patients with NPC. These patients can tolerate the aggressive definitive management of radiotherapy and chemotherapy with supportive care. © 2010 Wiley Periodicals, Inc. Head Neck, 2012</description><subject>Adult</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Chemotherapy, Adjuvant</subject><subject>Epstein–Barr virus</subject><subject>Female</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>immune thrombocytopenia</subject><subject>IMRT</subject><subject>Male</subject><subject>Medical sciences</subject><subject>nasopharyngeal cancer</subject><subject>Nasopharyngeal Neoplasms - complications</subject><subject>Nasopharyngeal Neoplasms - drug therapy</subject><subject>Nasopharyngeal Neoplasms - radiotherapy</subject><subject>Otorhinolaryngology. Stomatology</subject><subject>paraneoplastic syndrome</subject><subject>Paraneoplastic Syndromes - diagnosis</subject><subject>Paraneoplastic Syndromes - drug therapy</subject><subject>Platelet diseases and coagulopathies</subject><subject>Purpura, Thrombocytopenic, Idiopathic - diagnosis</subject><subject>Purpura, Thrombocytopenic, Idiopathic - drug therapy</subject><subject>Radiotherapy, Intensity-Modulated</subject><subject>Tumors</subject><subject>Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</subject><issn>1043-3074</issn><issn>1097-0347</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10DtPwzAQB3ALgaAUBr4A8oIQQ9qznUczovJopUosMDFEF-dCjRInxIlQvz3uAzEx2br76e70Z-xKwEQAyOmaiokU4UwcsZGANAlAhcnx9h-qQEESnrFz5z4BQMWhPGVnEuI4SkI5Yu_Luh4s8X7dNXXe6E3ftGQNcnQceYsdWmraCl1vNHcbW3hG3Fjf6g3Z3vFv06-5Rde0a-w29oOw4hqtpu6CnZRYObo8vGP29vT4Ol8Eq5fn5fx-FWgVhSJAwBTjUpGkHHOIIxHJSIIQRYLkqyIvpFazHJJEi7gsBSnEgma6TFWKQqkxu93PbbvmayDXZ7Vxmqpqe_vgslSIVMUgpZd3e6m7xrmOyqztTO3PzgRk2ygzH2W2i9Lb68PUIa999Vf-ZufBzQGg01iVPipt3J-LIpDhzk337ttUtPl_Y7Z4fNiv_gH0DIvS</recordid><startdate>201201</startdate><enddate>201201</enddate><creator>Yang, Kunyu</creator><creator>Zhang, Tao</creator><creator>Chen, Jing</creator><creator>Fan, Li</creator><creator>Yin, Zhongyuan</creator><creator>Hu, Yu</creator><creator>Wu, Gang</creator><creator>Rosenthal, Eben L.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201201</creationdate><title>Immune thrombocytopenia as a paraneoplastic syndrome in patients with nasopharyngeal cancer</title><author>Yang, Kunyu ; Zhang, Tao ; Chen, Jing ; Fan, Li ; Yin, Zhongyuan ; Hu, Yu ; Wu, Gang ; Rosenthal, Eben L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3541-a0a9a6f3e2ebab06515252011d7ae3e21bd2c38b077c16ff1e3aade8cf939a133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Chemotherapy, Adjuvant</topic><topic>Epstein–Barr virus</topic><topic>Female</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>immune thrombocytopenia</topic><topic>IMRT</topic><topic>Male</topic><topic>Medical sciences</topic><topic>nasopharyngeal cancer</topic><topic>Nasopharyngeal Neoplasms - complications</topic><topic>Nasopharyngeal Neoplasms - drug therapy</topic><topic>Nasopharyngeal Neoplasms - radiotherapy</topic><topic>Otorhinolaryngology. Stomatology</topic><topic>paraneoplastic syndrome</topic><topic>Paraneoplastic Syndromes - diagnosis</topic><topic>Paraneoplastic Syndromes - drug therapy</topic><topic>Platelet diseases and coagulopathies</topic><topic>Purpura, Thrombocytopenic, Idiopathic - diagnosis</topic><topic>Purpura, Thrombocytopenic, Idiopathic - drug therapy</topic><topic>Radiotherapy, Intensity-Modulated</topic><topic>Tumors</topic><topic>Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Kunyu</creatorcontrib><creatorcontrib>Zhang, Tao</creatorcontrib><creatorcontrib>Chen, Jing</creatorcontrib><creatorcontrib>Fan, Li</creatorcontrib><creatorcontrib>Yin, Zhongyuan</creatorcontrib><creatorcontrib>Hu, Yu</creatorcontrib><creatorcontrib>Wu, Gang</creatorcontrib><creatorcontrib>Rosenthal, Eben L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Head &amp; neck</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Kunyu</au><au>Zhang, Tao</au><au>Chen, Jing</au><au>Fan, Li</au><au>Yin, Zhongyuan</au><au>Hu, Yu</au><au>Wu, Gang</au><au>Rosenthal, Eben L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune thrombocytopenia as a paraneoplastic syndrome in patients with nasopharyngeal cancer</atitle><jtitle>Head &amp; neck</jtitle><addtitle>Head Neck</addtitle><date>2012-01</date><risdate>2012</risdate><volume>34</volume><issue>1</issue><spage>127</spage><epage>130</epage><pages>127-130</pages><issn>1043-3074</issn><eissn>1097-0347</eissn><abstract>Background Nasopharyngeal cancer (NPC) presenting with thrombocytopenia is rare. This report details 2 cases of NPC with grade III thrombocytopenia as a paraneoplastic syndrome. Methods We present 2 cases of NPC in whom grade III thrombocytopenia was diagnosed concurrently at presentation. One patient underwent definitive intensity‐modulated radiation therapy (IMRT) in combination with concurrent cetuximab, the other with cisplatin. Both patients received adjuvant chemotherapy composed of docetaxel and cisplatin. Results The cause of their grade III thrombocytopenia was diagnosed as immunologic in origin. Prednisone was administered before IMRT, and their peripheral platelet counts recovered to normal levels. Their platelet counts fell below normal levels several times during their treatment. However, their radiotherapy and chemotherapy had never been interrupted due to thrombocytopenia. Conclusion Grade III thrombocytopenia is a rare paraneoplastic syndrome in patients with NPC. These patients can tolerate the aggressive definitive management of radiotherapy and chemotherapy with supportive care. © 2010 Wiley Periodicals, Inc. Head Neck, 2012</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>20665742</pmid><doi>10.1002/hed.21481</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1043-3074
ispartof Head & neck, 2012-01, Vol.34 (1), p.127-130
issn 1043-3074
1097-0347
language eng
recordid cdi_proquest_miscellaneous_911936022
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adult
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Biological and medical sciences
Chemotherapy, Adjuvant
Epstein–Barr virus
Female
Hematologic and hematopoietic diseases
Humans
immune thrombocytopenia
IMRT
Male
Medical sciences
nasopharyngeal cancer
Nasopharyngeal Neoplasms - complications
Nasopharyngeal Neoplasms - drug therapy
Nasopharyngeal Neoplasms - radiotherapy
Otorhinolaryngology. Stomatology
paraneoplastic syndrome
Paraneoplastic Syndromes - diagnosis
Paraneoplastic Syndromes - drug therapy
Platelet diseases and coagulopathies
Purpura, Thrombocytopenic, Idiopathic - diagnosis
Purpura, Thrombocytopenic, Idiopathic - drug therapy
Radiotherapy, Intensity-Modulated
Tumors
Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology
title Immune thrombocytopenia as a paraneoplastic syndrome in patients with nasopharyngeal cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T10%3A32%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune%20thrombocytopenia%20as%20a%20paraneoplastic%20syndrome%20in%20patients%20with%20nasopharyngeal%20cancer&rft.jtitle=Head%20&%20neck&rft.au=Yang,%20Kunyu&rft.date=2012-01&rft.volume=34&rft.issue=1&rft.spage=127&rft.epage=130&rft.pages=127-130&rft.issn=1043-3074&rft.eissn=1097-0347&rft_id=info:doi/10.1002/hed.21481&rft_dat=%3Cproquest_cross%3E911936022%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=911936022&rft_id=info:pmid/20665742&rfr_iscdi=true